Input sequence

Protein name Neurexin-2
Organism Mus musculus Length 1710
Disorder content 20.9% ProS content 17.0%
IDEAL NA UniProt E9Q7X7

Prediction

Order Disorder ProS BLAST:PDB RPS-BLAST:PDB RPS-BLAST:PDB RPS-BLAST:PDB RPS-BLAST:Pfam RPS-BLAST:Pfam RPS-BLAST:Pfam RPS-BLAST:Pfam RPS-BLAST:Pfam RPS-BLAST:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam HMMER:Pfam RPS-BLAST:SCOP RPS-BLAST:SCOP RPS-BLAST:SCOP RPS-BLAST:SCOP RPS-BLAST:SCOP RPS-BLAST:SCOP RPS-BLAST:SCOP RPS-BLAST:SCOP RPS-BLAST:SCOP HMMER:SCOP HMMER:SCOP HMMER:SCOP HMMER:SCOP HMMER:SCOP HMMER:SCOP SEG:LCR TMHMM:TMhelix 0 1710 1-19 20-536 537-541 542-676 677-690 691-1023 1024-1030 1031-1349 1350-1633 1634-1670 1671-1710 20-536 542-676 691-1023 1031-1349 1634-1670 1-19 677-690 1350-1633 1671-1710 1-19 677-690 1350-1380 1388-1463 1477-1524 1532-1538 1556-1584 1589-1633 1671-1677 1683-1687 1702-1710 287-1342 287-1342 100-186 206-245 946-1074 318-454 760-890 1169-1254 521-669 98-188 57-187 206-241 318-459 521-666 760-890 946-1074 1100-1132 1169-1318 918-1078 712-904 493-687 98-188 286-487 1135-1335 693-729 206-245 1105-1134 27-219 226-487 493-705 711-892 899-1111 1117-1320 8-24 65-90 268-276 558-573 1347-1377 1433-1454 1637-1652 1687-1706 1634-1656 3qcwA(1-1002) 0.0 71.9% 3qcwA(1-1002) 7e-155 71.33% 1dykA(266-348) 4e-05 26.14% 1eqgA(4-41) 4e-06 32.5% PF02210(1-126) 1e-17 42.42% PF02210(1-121) 3e-10 33.81% PF02210(1-126) 1e-08 32.09% PF02210(1-85) 2e-07 36.05% PF00054(1-132) 6e-14 39.61% PF00054(42-130) 0.0003 30.11% PF02210 3.6e-32 117.5% PF00008 0.00096 23.0% PF02210 1.8e-30 111.8% PF02210 8.6e-42 149.4% PF02210 6.5e-24 90.0% PF02210 9.5e-41 146.0% PF00008 4.6e-05 27.4% PF02210 3.4e-20 77.7% 1dykA1(16-175) 4e-22 25.0% 1dykA1(2-187) 5e-17 16.58% 1dykA1(16-188) 5e-16 22.84% 1dykA1(86-172) 9e-09 21.98% 1dykA2(2-184) 8e-15 15.69% 1c4rA(2-172) 2e-15 66.67% 1cqeA2(4-41) 1e-07 39.47% 1cqeA2(5-42) 4e-07 32.5% 1h30A1(2-31) 0.0002 20.0% b.29.1 4.6e-43 104.9% b.29.1 2.6e-42 103.0% b.29.1 2.6e-47 115.4% b.29.1 7.7e-39 94.4% b.29.1 3.8e-50 122.4% b.29.1 9.7e-38 91.7%

Sequence

MALGSRWQPPPQLPPLLLLLALAAGVRGLEFGGGPGQWARYARWAGAASTGELSFSLRTN
ATRALLLYLDDGGDCDFLELLLVDGRLRLRFTLSCAEPATLQLDTPVADDRWHMVLLTRD
ARRTALAVDGEARAAEVRSKRREMQVASDLFVGGIPPDVRLSALTLSTVKYEPPFRGLLA
NLKLGERPPALLGSQGLRGAAADPLCAPARNPCANGGLCTVLAPGEVGCDCSHTGFGGKF
CSEEEHPMEGPAHLTLNSEVGSLLFSEGGAGRGGAGDVHQPTKGKEEFVATFKGNEFFCY
DLSHNPIQSSTDEITLAFRTLQRNGLMLHTGKSADYVNLSLKSGAVWLVINLGSGAFEAL
VEPVNGKFNDNAWHDVRVTRNLRQHAGIGHAMVNKLHYLVTISVDGILTTTGYTQEDYTM
LGSDDFFYIGGSPNTADLPGSPVSNNFMGCLKDVVYKNNDFKLELSRLAKEGDPKMKLQG
DLSFRCEDVAALDPVTFESPEAFVALPRWSAKRTGSISLDFRTTEPNGLLLFSQGRRAGA
GVGSHSSTQRADYFAMELLDGYLYLLLDMGSGGIKLRASSRKVNDGEWCHVDFQRDGRKG
SISVNSRSTPFLATGESEVLDLESELYLGGLPEGGRVDLPLPPEVWTAALRAGYVGCVRD
LFIDGRSRDLRGLAEAQGAVGVAPFCSRETLKQCASAPCRNGGICREGWNRFVCDCIGTG
FLGRVCEREATVLSYDGSMYMKIMLPTAMHTEAEDVSLRFMSQRAYGLMMATTSRESADT
LRLELDGGQMRLTVNLDCLRVGCAPSKGPETLFAGHKLNDNEWHTVRVVRRGKSLQLSVD
NVTVEGQMAGAHTRLEFHNIETGIMTERRFISVVPSNFIGHLSGLVFNGQPYMDQCKDGD
ITYCELNARFGLRAIVADPVTFKSRSSYLALATLQAYASMHLFFQFKTTAPDGLLLFNSG
NGNDFIVIELVKGYIHYVFDLGNGPSLMKGNSDKPVNDNQWHNVVVSRDPGNVHTLKIDS
RTVTQHSNGARNLDLKGELYIGGLSKNMFSNLPKLVASRDGFQGCLASVDLNGRLPDLIA
DALHRIGQVERGCDGPSTTCTEESCANQGVCLQQWDGFTCDCTMTSYGGPVCNDPGTTYI
FGKGGALITYTWPPNDRPSTRMDRLAVGFSTHQRSAVLVRVDSASGLGDYLQLHIDQGTV
GVIFNVGTDDITIDEPNAIVSDGKYHVVRFTRSGGNATLQVDSWPVNERYPAGNFDNERL
AIARQRIPYRLGRVVDEWLLDKGRQLTIFNSQAAIKIGGRDQGRPFQGQVSGLYYNGLKV
LALAAESDPNVRTEGHLRLVGEGPSVLLSAETTATTLLADMATTIMETTTTMATTTTRRG
RSPTMRDSTTQNTDDLLVASAECPSDDEDLEECEPSTGGELILPIITEDSLDPPPVATRS
PFVPPPPTFYPFLTGVGATQDTLPPPAARRPSSGGPCQAERDDSDCEEPVEASGFASGEV
FDSSLPPTDDEDFYTTFPLVTDRTTLLSPRKPRPNLRTDGATGAPGVLFAPSAPAPNLPA
GKMNHRDPLQPLLENPPLGPGVPTAFEPRRPPPLRPGVTSAPGFPRLPTANPTGPGERGP
PGAVEVIRESSSTTGMVVGIVAAAALCILILLYAMYKYRNRDEGSYQVDQSRNYISNSAQ
SNGAVVKEKAPAAPKTPSKAKKNKDKEYYV

Region:1-1710
Length:1710aa
Label:Full sequence
Reset:click